# OnCo record rhythm-pharmaceuticals (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/rhythm-pharmaceuticals/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "rhythm-pharmaceuticals" ;
  schema:name "Rhythm Pharmaceuticals"@en ;
  schema:alternateName "Rhythm Pharmaceuticals, Inc."@en, "NASDAQ:RYTM"@en ;
  schema:description "Rhythm Pharmaceuticals is a Boston company whose MC4R agonist setmelanotide, sold as Imcivree, treats the uncontrolled hunger and obesity of rare genetic disorders and of damage to the hypothalamus, including after treatment for craniopharyngioma and other brain tumours."@en ;
  schema:url <https://onco.cc/companies/rhythm-pharmaceuticals/>, <https://www.rhythmtx.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.rhythmtx.com/> ;
  onco:tag "drug-maker" ;
  schema:addressCountry "US" ;
  onco:drugs <https://onco.cc/drugs/setmelanotide/> .